Literature DB >> 3781178

Barrett's esophagus. A prevalent, occult complication of gastroesophageal reflux disease.

C Winters, T J Spurling, S J Chobanian, D J Curtis, R L Esposito, J F Hacker, D A Johnson, D F Cruess, J D Cotelingam, M S Gurney.   

Abstract

A prospective study of patients with symptoms of gastroesophageal reflux was undertaken to determine the prevalence of Barrett's esophagus and reevaluate the diagnostic approach necessary to detect this complication. Endoscopy with mucosal biopsy was performed in 97 subjects. Twelve (12.4%) were found to have Barrett's esophagus. The sensitivity and specificity of the endoscopic and radiologic examinations for Barrett's esophagus were prospectively evaluated. Endoscopy (92%) was significantly more sensitive than radiology (24%) in detecting Barrett's esophagus (p less than 0.001). The frequency and severity of reflux symptoms among patients determined to have Barrett's esophagus, reflux esophagitis, or normal esophageal biopsies were quantitatively similar in all three groups, except for significantly greater daytime heartburn in those with reflux esophagitis (p less than 0.01). These data indicate that Barrett's esophagus complicates gastroesophageal reflux more often than previously believed.

Entities:  

Mesh:

Year:  1987        PMID: 3781178

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  156 in total

1.  An evidence-based appraisal of reflux disease management--the Genval Workshop Report.

Authors: 
Journal:  Gut       Date:  1999-04       Impact factor: 23.059

Review 2.  Molecular evolution of the metaplasia-dysplasia-adenocarcinoma sequence in the esophagus.

Authors:  J A Jankowski; N A Wright; S J Meltzer; G Triadafilopoulos; K Geboes; A G Casson; D Kerr; L S Young
Journal:  Am J Pathol       Date:  1999-04       Impact factor: 4.307

3.  The pathogenesis of Barrett's esophagus: a process in continuum or discontinuum.

Authors:  R C Fitzgerald; M J Farthing
Journal:  Curr Gastroenterol Rep       Date:  2000-12

4.  Cytochromes P450 are expressed in proliferating cells in Barrett's metaplasia.

Authors:  S J Hughes; M A Morse; C M Weghorst; H Kim; P B Watkins; F P Guengerich; M B Orringer; D G Beer
Journal:  Neoplasia       Date:  1999-06       Impact factor: 5.715

5.  Gastroesophageal reflux disease is uncommon in Asia: evidence and possible explanations.

Authors:  Khek-Yu Ho
Journal:  World J Gastroenterol       Date:  1999-02       Impact factor: 5.742

6.  Parathyroid hormone-related protein production by adenocarcinoma in Barrett's esophagus patient with dermatomyositis.

Authors:  S Tanabe; H Mitomi; M Sada; I Yamazaki; T Akaboshi; I Okayasu; T Kameya; K Saigenji
Journal:  Dig Dis Sci       Date:  2001-07       Impact factor: 3.199

7.  Preoperative chemotherapy unmasks underlying Barrett's mucosa in patients with adenocarcinoma of the distal esophagus.

Authors:  J Theisen; H J Stein; H J Dittler; M Feith; C Moebius; W K H Kauer; M Werner; J R Siewert
Journal:  Surg Endosc       Date:  2002-01-09       Impact factor: 4.584

Review 8.  Oesophageal surgery.

Authors:  E J Simchuk; D Alderson
Journal:  World J Gastroenterol       Date:  2001-12       Impact factor: 5.742

Review 9.  Endoscopic ablation of Barrett's esophagus.

Authors:  M B Fennerty
Journal:  Curr Gastroenterol Rep       Date:  1999-06

10.  Impact of endoscopic biopsy surveillance of Barrett's oesophagus on pathological stage and clinical outcome of Barrett's carcinoma.

Authors:  J W van Sandick; J J van Lanschot; B W Kuiken; G N Tytgat; G J Offerhaus; H Obertop
Journal:  Gut       Date:  1998-08       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.